Recombinant Human TWEAK Receptor/TNFRSF12A

Description :
FAQ COA 已发表文献 TWEAKR belongs to the TNF family of transmembrane proteins, and contains a cytoplasmic “death domain”, which can activate a cell’s apoptotic machinery. It is expressed in the spleen, thymus, peripheral blood lymphocytes, colon, and small intestine. Signal transduction by TWEAKR can be activated by either membrane-anchored or soluble TWEAK. Recombinant Human solubleTWEAKR is a 53 amino acid polypeptide (5.6 kDa) comprising the entire extracellular domain of the full-length TWEAKR protein. Product Properties Synonyms TNFRSF12A, FGF-inducible 14, CD266 Accession Q9NP84 GeneID 51330 Source E.coli-derived Human TWEAK Receptor/TNFRSF12Aprotein,Glu28-Pro80. Molecular Weight Approximately 5.6 kDa AA Sequence EQAPGTAPCS RGSSWSADLD KCMDCASCRA RPHSDFCLGC AAAPPAPFRL LWP Tag None Physical Appearance Sterile Filtered White lyophilized (freeze-dried) powder. Purity > 95% by SDS-PAGE and HPLC analyses. Biological Activity The ED50as determined by inhibiting TWEAK-dependent proliferation of human umbilical vein endothelial cells (HUVEC) is less than 30 ng/ml, corresponding to a specific activity of > 3.3 104IU/mg, in the presence of 15 ng/mLof rHuTWEAK.Fully biologically active when compared to standard. Endotoxin Formulation Lyophilized from a 0.2 m filtered concentrated solution in PBS, pH 7.4. Reconstitution We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at -20C. Further dilutions should be made in appropriate buffered solutions.